CurrentEndo coverage · page 44 of 55

Diabetes, Obesity and Metabolism

Briefs 1,721–1,760 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab29 Feb 2024
A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
Randomized controlled trialT2D & other
Diabetes Obes Metab28 Feb 2024
Associations of body mass index trajectory, waist circumference trajectory, or both with type 2 diabetes mellitus risk in Chinese adults: The China‐PAR project
Cohort studyT2D & other
Diabetes Obes Metab28 Feb 2024
Real‐world glycated haemoglobin changes among type 2 diabetes mellitus patients treated with a maintenance dose of 7 mg or 14 mg of oral semaglutide
Cohort studyT2D & other
Diabetes Obes Metab28 Feb 2024
The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD‐REIN cohort study
Cohort studyComplications
Diabetes Obes Metab28 Feb 2024
Bridging dose of U‐100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice‐daily glargine users
Randomized controlled trialT1D
Diabetes Obes Metab28 Feb 2024
Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study
Cohort studyObesity
Diabetes Obes Metab28 Feb 2024
Insulin resistance before type 2 diabetes onset is associated with increased risk of albuminuria after diabetes onset: A prospective cohort study
Cohort studyT2D & other
Diabetes Obes Metab28 Feb 2024
Pharmacological treatment of obesity in adults in Norway 2004–2022
Cohort studyObesity
Diabetes Obes Metab27 Feb 2024
Renal outcomes with sodium‐glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases
Cohort studyT2D & other
Diabetes Obes Metab26 Feb 2024
Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
Cohort studyTechnology
Diabetes Obes Metab26 Feb 2024
Associations of a proinflammatory diet, habitual salt intake, and the onset of type 2 diabetes: A prospective cohort study from the UK Biobank
Cohort studyT2D & other
Diabetes Obes Metab26 Feb 2024
Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta‐analysis of trials investigating intensive glucose‐lowering strategies in people with type 2 diabetes
Meta-analysisT2D & other
Diabetes Obes Metab23 Feb 2024
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab21 Feb 2024
Evaluating different low‐density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
Research articleT2D & other
Diabetes Obes Metab21 Feb 2024
Geographic and ethnicity variation in the prevalence of middle‐aged and elderly adult obesity in China in 2020
Cross-sectional studyObesity
Diabetes Obes Metab20 Feb 2024
Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents
Meta-analysisT2D & other
Diabetes Obes Metab20 Feb 2024
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes
Randomized controlled trialT1D
Diabetes Obes Metab16 Feb 2024
Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population‐based cohort study with Mendelian randomization
Cohort study
Diabetes Obes Metab15 Feb 2024
Comparative analysis of hospitalization risk for incident heart failure in non‐Hispanic Black versus non‐Hispanic White individuals with type 2 diabetes on empagliflozin (Empa‐AA): Insights from real‐world data
Cohort studyT2D & other
Diabetes Obes Metab14 Feb 2024
County‐level socio‐environmental factors and obesity prevalence in the United States
Cross-sectional studyObesity
Diabetes Obes Metab14 Feb 2024
Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity‐score‐matched retrospective cohort study
Cohort studyT2D & other
Diabetes Obes Metab8 Feb 2024
IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study
Cohort studyT2D & other
Diabetes Obes Metab7 Feb 2024
Erythropoiesis and estimated fluid volume regulation following initiation of ipragliflozin treatment in patients with type 2 diabetes mellitus and chronic kidney disease: A post‐hoc analysis of the PROCEED trial
Secondary analysisT2D & other
Diabetes Obes Metab6 Feb 2024
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial
Secondary analysisT2D & other
Diabetes Obes Metab5 Feb 2024
Counting the lifetime cost of obesity: Analysis based on national England data
Research articleObesity
Diabetes Obes Metab5 Feb 2024
Higher early pregnancy plasma myo ‐inositol associates with increased postprandial glycaemia later in pregnancy: Secondary analyses of the NiPPeR randomized controlled trial
Secondary analysisDiabetes in pregnancy
Diabetes Obes Metab5 Feb 2024
Uric acid‐lowering effects of sodium‐glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab1 Feb 2024
Branched‐chain amino acid levels are inversely associated with incident and prevalent chronic kidney disease in people with type 2 diabetes
Cohort studyT2D & other
Diabetes Obes Metab1 Feb 2024
Age‐ and gender‐adjusted estimated glomerular filtration rate definition reveals hyperfiltration as a risk factor for renal function deterioration in type 2 diabetes
Cohort studyT2D & other
Diabetes Obes Metab1 Feb 2024
Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study
Cohort studyLipids & liver
Diabetes Obes Metab1 Feb 2024
Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS‐AP‐Combo
Secondary analysisT2D & other
Diabetes Obes Metab1 Feb 2024
A meta‐analysis of diabetes risk prediction models applied to prediabetes screening
Meta-analysisT2D & other
Diabetes Obes Metab31 Jan 2024
Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank
Diagnostic or prognostic studyT2D & other
Diabetes Obes Metab31 Jan 2024
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study
Randomized controlled trialT2D & other
Diabetes Obes Metab31 Jan 2024
Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post‐hoc machine learning analysis of ACCORD trial data
Secondary analysisT2D & other
Diabetes Obes Metab30 Jan 2024
Use of sodium‐glucose cotransporter‐2 inhibitors in France: Analysis of French nationwide health insurance database
Cross-sectional studyT2D & other
Diabetes Obes Metab29 Jan 2024
Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills
Cohort studyObesity
Diabetes Obes Metab29 Jan 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin‐4‐IgG4‐Fc in healthy subjects: A phase 1, single‐centre, randomized, double‐blind, dose escalation study
Randomized controlled trialT2D & other
Diabetes Obes Metab29 Jan 2024
Obesity management from the perspectives of people living with obesity in Canada: A mixed‐methods study
Research articleObesity
Diabetes Obes Metab22 Jan 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study
Cohort studyT1D

All 2,200 Briefs in ExploreShowing Briefs 1,721–1,760 of 2,200, newest first